Castle Biosciences said it will present new data on its DecisionDx-Melanoma test at two specialist meetings in November. The readouts are slated for the SDPA Fa

BWB News TV • 2026-11-11 22:27 UTC • By Billy Odell Tucker-Robinson

Castle Biosciences said it will present new data on its DecisionDx-Melanoma test at two specialist meetings in November. The readouts are slated for the SDPA Fall Dermatology Conference in Florida and Europe’s Dermato-Onco2026.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly